Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Raw Materials (2022 - 2025)

Historic Raw Materials for Innoviva (INVA) over the last 7 years, with Q3 2025 value amounting to $14.4 million.

  • Innoviva's Raw Materials rose 5089.76% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year increase of 5089.76%. This contributed to the annual value of $11.1 million for FY2024, which is 127.92% down from last year.
  • According to the latest figures from Q3 2025, Innoviva's Raw Materials is $14.4 million, which was up 5089.76% from $10.5 million recorded in Q2 2025.
  • Innoviva's Raw Materials' 5-year high stood at $14.4 million during Q3 2025, with a 5-year trough of $5.8 million in Q3 2022.
  • Moreover, its 4-year median value for Raw Materials was $9.5 million (2024), whereas its average is $9.3 million.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 9553.59% in 2023, then plummeted by 127.92% in 2024.
  • Over the past 4 years, Innoviva's Raw Materials (Quarter) stood at $5.8 million in 2022, then skyrocketed by 95.54% to $11.3 million in 2023, then dropped by 1.28% to $11.1 million in 2024, then increased by 29.34% to $14.4 million in 2025.
  • Its Raw Materials stands at $14.4 million for Q3 2025, versus $10.5 million for Q2 2025 and $10.6 million for Q1 2025.